ICTSD: Specialised Intellectual Property Courts – Issues And Challenges 20/05/2016 by Intellectual Property Watch 1 Comment The establishment of the WTO Agreement on TRIPS (Trade Related Aspects of Intellectual Property Rights) and the proliferation of plurilateral, bilateral and regional agreements have significantly contributed to the increasing complexities of the intellectual property system. The emergence of new actors, reflecting conflicting expectations and the adoption of new trade agreements that often exceed the standards set by the TRIPS agreement, have resulted in a new density of rules that have further fragmented the international system. These developments have unavoidably called for further analysis by academics and stakeholders.
Can Patents Ever Be “Ever-Greened”? The Answer…They Are “Never-Greened” 20/05/2016 by Intellectual Property Watch 9 Comments “Ever-Greening of Patents” has been an expression that has been extensively used in debates related to the global pharmaceutical industry at least since the last two decades. Interestingly, this term has never been statutorily defined and hence has been applied most freely by professionals, policy makers and politicians alike. It would be appropriate to objectively examine whether patents in any jurisdiction can ever be “ever-greened”. A fitting initiation to this debate is the very concept of what a patent is from the very first principles, writes Prabuddha Ganguli.
Washington Post- Colombia Battles World’s Biggest Drugmaker Over Cancer Drug 19/05/2016 by Intellectual Property Watch Leave a Comment [From the Washington Post] BOGOTA, Colombia — Colombia’s government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
USITC Finds TPP Benefits US Economy, But Maybe Not Jobs; Unclear On IP Rights 19/05/2016 by Intellectual Property Watch 1 Comment The United States International Trade Commission (ITC), an independent government agency, today released an 800-page analysis of the economic impact of the Trans-Pacific Partnership (TPP) Agreement completed last year.
Innovation And Access: Fission Or Fusion? Interview with David Taylor, Professor of Pharmaceutical and Public Health Policy, University College London, UK 18/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with David Taylor, Professor of Pharmaceutical and Public Health Policy, University College London, UK.
Biggest World Health Assembly Ever Kicks Off Next Week With A Loaded Agenda 18/05/2016 by Catherine Saez and William New, Intellectual Property Watch 3 Comments Next week the annual assembly of World Health Organization member states will take place with a heavy agenda and its largest attendance ever. The lack of new antibiotics to address bacterial resistance, global shortages of vaccines and medicines, the fight against substandard drugs, and a framework to guard against undue influence of outside actors on the work of the WHO are part of a picture where there is an increasing blur between developed and developing countries in terms of access to medicines. And then there is the matter of electing a new WHO director general.
WHO Seeks USD160m For Role Change To Coordinate Global Emergencies 18/05/2016 by William New, Intellectual Property Watch 1 Comment At its annual Assembly next week, the World Health Organization will seek member state approval of US$160 million over two years to establish its role as a global coordinator for health emergencies. Image Credits: UN
EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing Countries 17/05/2016 by Tatum Anderson for Intellectual Property Watch 1 Comment Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive overhaul. A revamp has been proposed because it is underused – just a handful of products have gone through the Article 58 process since its launch in 2004. The most recent is an antiseptic chlorhexidine gel that prevents new-born umbilical cord infections in developing countries. A joint project between GSK and Save the Children, it was approved late last month.
Business Report On Adjudicating IP Disputes In Specialised Jurisdictions Worldwide 16/05/2016 by Intellectual Property Watch Leave a Comment The International Chamber of Commerce (ICC) has released a report that examines specialised intellectual property courts around the world.
India Releases New Intellectual Property Policy; Reactions Building 13/05/2016 by William New and Patralekha Chatterjee for Intellectual Property Watch 4 Comments The Indian government today released its long-awaited new intellectual property policy, and preliminary reactions appear to be that it caters to international pressures while attempting to provide a national focus. A more careful reading with reactions will follow.